The Quality Colloquim - The Leading Forum on Health Care Quality Enhancement and Medical Error Reduction

Overview | Agenda | Continuing Education | Promotional Opportunities
Registration | Hotel/Travel | Contact Us | Privacy Policy | Admin | Home

Symposium Overview
Rarely have there been so many major changes and uncertainties with such far-reaching consequences to drug development, manufacturing, monitoring and marketing. And rarely has there been a greater need to bring together representatives and advisors from government and the world's leading drugmakers to share strategies for regaining consumer confidence in today's medicines.

The FDA Regulatory and Compliance Symposium-a unique three-day, high-level forum in one of the world's most famous academic settings-will help drugmakers prepare for the full impact of all the changes flowing from the FDA and Congress, while clarifying many of the uncertainties. The Symposium will also provide practical, state-of-the-art solutions to the challenges of eliminating or reducing risks throughout the product life-cycle-from the drug pipeline to manufacturing to patient delivery.


The Symposium takes place on the campus of Harvard University. Classes are held in Annenberg Hall of the Sanders Theatre Complex. Inspired by the great halls of Oxford and Cambridge Universities, this room is arguably the most impressive space at Harvard. Harvard University, the oldest institution of higher learning in the United States, was established in 1636. Today, Harvard has grown to become a great undergraduate and graduate research university, with more than 18,000 degree candidates enrolled.

Who Should Attend:

Senior executives, compliance officers and managers of pharmaceutical companies, especially those responsible for the oversight of:

  • Regulatory affairs
  • Pharmacovigilance
  • Drug manufacturing
  • Quality management systems
  • Medical affairs
  • Clinical research
  • Risk management
  • Sales and marketing
  • Labeling
  • Legal affairs
Who Else Will Be There:

Meet and learn from top compliance and risk management experts from:

  • Actelion Pharmaceuticals
  • APCO Worldwide
  • Abbott Laboratories Ross Products Division
  • Allergan
  • Baxter Healthcare
  • Biogen Idec
  • Cambrex Bioscience
  • Covance Periapproval Services
  • EduQuest
  • Eli Lilly
  • Genzyme
  • Kendle
  • Louis A. Morris & Associates
  • Purdue Pharma
  • The Quantic Group
  • sanofi-aventis
  • TAP Pharmaceuticals
  • Wyeth Pharmaceuticals
  • ...and more!
Learning Objectives:
  • To describe best industry practices for managing drug safety risks
  • To examine the latest changes at the FDA-including new people, policies and priorities-and prepare for more changes to come
  • To share ideas and discuss specific successful strategies for reducing risks throughout the life cycle of a product- from development to delivery, from bench to bedside
  • To reduce risks, improve quality and cut costs in manufacturing processes
  • To reduce risks and accelerate regulatory approvals in new product development
  • To reduce risks and minimize liabilities in product marketing and advertising
  • To meet heightened FDA expectations for pharmacovigilance
  • To implement proven techniques for internal compliance and risk auditing
  • To benchmark risk management strategies against several of the top pharmaceutical and biologic companies in the world
Symposium Sponsors:

FDAnews is the premier provider of global regulatory, legislative and business news and information for professionals in industries regulated by the U.S. Food and Drug Administra-tion and the European Commission. Pharmaceutical and medical device professionals rely on FDAnews' conferences, print and electronic newsletters, and books to stay in compliance with international standards and the FDA's complex and ever-changing regulations. For further information on FDAnews, visit

The Harvard Health Policy Review,, is dedicated to broadening awareness of health policy issues. HHPR aims to educate people about healthcare policy and to stimulate thinking about the pressing health care questions facing the nation and the world. The HHPR is published by Exploring Policy in Health Care at Harvard (EPIHC), an organization of Harvard undergraduates whose main purpose is to encourage discussion of health policy issues on the Harvard campus. The HHPR is supported by the University-wide Interfaculty Initiative in Health Policy.

Health Affairs,, is the leading journal of health policy thought and research. Health Affairs is a multidisciplinary journal covering a wide range of health issues. Topics covered include: access to care, health spending, quality, Medicare, Medicaid, prescription drug coverage and costs, physician practice, nursing trends, mental health, malpractice and health law, insurance reform, hospitals, global health, and disparities in health care, among others. Health Affairs is frequently cited by national media, including the The Washington Post, The New York Times, The Wall Street Journal, CNN, network television and radio, and National Public Radio. The January 12, 2005 The Washington Post cited Health Affairs as "the bible of health policy."

Overview | Agenda | Continuing Education | Promotional Opportunities
Registration | Hotel/Travel | Contact Us | Privacy Policy | Admin | Home

Copyright @ 2005 by Health Care Conference Administrators, LLC. and Washington Business Information, Inc.
Contact Webmaster